Photo of Yakeel T. Quiroz-Gaviria, PhD

Quiroz-Gaviria, Yakeel T., PhD

  • Co-Director, MGH Multicultural Neuropsychology Program (MUNDOS)


Accepting New Patients




Clinical Interests
  • Neuropsychological assessment of adults
  • Memory disorders
  • Early onset dementia
  • Alzheimer's disease
  • Brain health
  • Neurodegenerative conditions
  • Neuropsychiatric conditions (e.g., OCD, Depression)
Medical Education
  • MA, Boston University
  • PHD, Boston University
  • Fellowship, Massachusetts General Hospital
Foreign Languages
  • Spanish
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Great-West Healthcare (formally One Health Plan)
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Behavioral Health
  • United Behavioral Health - MGH

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group


Dr. Quiroz is a neuropsychologist and clinical researcher at Massachusetts General Hospital/Harvard Medical School. She completed her Ph.D. training in clinical psychology at Boston University and a postdoctoral fellowship in clinical neuropsychology at MGH.  Dr. Quiroz is co-director of the Multicultural Neuropsychology Program (MUNDOS) at MGH, a service that offers culturally and linguistically appropriate neuropsychological testing and interventions to Latino adults. Her research seeks to identify and validate biomarkers for early detection of Alzheimer’s disease. 

Research & Publications

Research Summary

View my most recent research

Dr. Quiroz's research is focused on the study of age-related cognitive and brain changes that may predispose individuals to develop dementia later in life. Understanding the pathophysiology of neurodegeneration and identifying preclinical biomarkers for early diagnosis of dementia, especially as measured by neuropsychology and neuroimaging, are fundamental goals for her research. Her current studies use multimodal neuroimaging (e.g. PET, sMRI, fMRI, DTI) and integrate genetic, molecular and neuropsychological data to characterize some of the earliest changes associated with dementia.


View my most recent publications at PubMed


Psychology Assessment Center
One Bowdoin Square
7th Floor
Boston, MA 02114-2927
Phone: 617-643-3997

Back to Top